These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 16367990)

  • 21. Clinical inquiries. How effective are pharmacologic agents for alcoholism?
    Hunt RR
    J Fam Pract; 2002 Jun; 51(6):577. PubMed ID: 12100788
    [No Abstract]   [Full Text] [Related]  

  • 22. Potential of buprenorphine/naltrexone in treating polydrug addiction and co-occurring psychiatric disorders.
    McCann DJ
    Clin Pharmacol Ther; 2008 Apr; 83(4):627-30. PubMed ID: 18212797
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fatal opiate overdose following regimen changes in naltrexone treatment.
    Oliver P; Horspool M; Keen J
    Addiction; 2005 Apr; 100(4):560-1. PubMed ID: 15784071
    [No Abstract]   [Full Text] [Related]  

  • 24. Evidence-based treatment of geriatric substance abuse.
    Oslin DW
    Psychiatr Clin North Am; 2005 Dec; 28(4):897-911, ix. PubMed ID: 16325734
    [No Abstract]   [Full Text] [Related]  

  • 25. "Narcotics helped, I thought." Recurrent traumatization and recovery from drug dependence.
    Kueppenbender K; Herman J; Khantzian E; Albanese M
    Harv Rev Psychiatry; 2008; 16(5):308-17. PubMed ID: 18803106
    [No Abstract]   [Full Text] [Related]  

  • 26. Characteristics of U.S. substance abuse treatment facilities adopting buprenorphine in its initial stage of availability.
    Koch AL; Arfken CL; Schuster CR
    Drug Alcohol Depend; 2006 Jul; 83(3):274-8. PubMed ID: 16413146
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The place of detoxification in treatment of opioid dependence.
    Gowing LR; Ali RL
    Curr Opin Psychiatry; 2006 May; 19(3):266-70. PubMed ID: 16612211
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Overcoming opioid blockade from depot naltrexone (Prodetoxon).
    Kruptisky EM; Burakov AM; Tsoy MV; Egorova VY; Slavina TY; Grinenko AY; Zvartau EE; Woody GE
    Addiction; 2007 Jul; 102(7):1164-5. PubMed ID: 17498182
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Buprenorphine in pregnancy: the advantages.
    Nocon JJ
    Addiction; 2006 Apr; 101(4):608. PubMed ID: 16548940
    [No Abstract]   [Full Text] [Related]  

  • 30. Caring for patients with opioid dependence.
    Bunker J; Winstock A; Zwar NA
    Aust Fam Physician; 2008; 37(1-2):57-60. PubMed ID: 18239755
    [TBL] [Abstract][Full Text] [Related]  

  • 31. What more do we need to know about medication-assisted treatment for prescription opioid abusers?
    Magura S
    Addiction; 2009 May; 104(5):784-5. PubMed ID: 19413789
    [No Abstract]   [Full Text] [Related]  

  • 32. Pharmacogenetic treatments for drug addiction: alcohol and opiates.
    Haile CN; Kosten TA; Kosten TR
    Am J Drug Alcohol Abuse; 2008; 34(4):355-81. PubMed ID: 18584566
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Urine testing in impaired physicians.
    Croughan J; Sanders K
    Mo Med; 1989 Jun; 86(6):341-2. PubMed ID: 2755454
    [No Abstract]   [Full Text] [Related]  

  • 34. Naltrexone as a "mandate" or as a choice comments on "Judicially mandated naltrexone use by criminal offenders: a legal analysis".
    Presenza LJ
    J Subst Abuse Treat; 2006 Sep; 31(2):129-30. PubMed ID: 16919738
    [No Abstract]   [Full Text] [Related]  

  • 35. The use of depot naltrexone under legal coercion: the case for caution.
    Hall W; Capps B; Carter A
    Addiction; 2008 Dec; 103(12):1922-4. PubMed ID: 19469728
    [No Abstract]   [Full Text] [Related]  

  • 36. Opiate addiction in China: current situation and treatments.
    Tang YL; Zhao D; Zhao C; Cubells JF
    Addiction; 2006 May; 101(5):657-65. PubMed ID: 16669899
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Asp40 mu-opioid receptor allele does not predict naltrexone treatment efficacy in heavy drinkers.
    Mitchell JM; Fields HL; White RL; Meadoff TM; Joslyn G; Rowbotham MC
    J Clin Psychopharmacol; 2007 Feb; 27(1):112-5. PubMed ID: 17224736
    [No Abstract]   [Full Text] [Related]  

  • 38. [Rapid detoxification under anesthesia: is it worth while to wait for research-based evidence?].
    Seppä K; Kaukinen S; Mehtonen OP; Poutanen P
    Duodecim; 1998; 114(20):2090-1. PubMed ID: 11717732
    [No Abstract]   [Full Text] [Related]  

  • 39. Research on naltrexone in the criminal justice system.
    Patapis NS; Nordstrom BR
    J Subst Abuse Treat; 2006 Sep; 31(2):113-5. PubMed ID: 16919735
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Naltrexone for the treatment of obesity: review and update.
    Lee MW; Fujioka K
    Expert Opin Pharmacother; 2009 Aug; 10(11):1841-5. PubMed ID: 19537999
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.